Comparison of treatment outcomes and complications of short-term and long-term brachytherapy in patients with cervical cancer

acute and subacute complications of short course brachytherapy compared with conventional brachytherapy treatment in patients with cervical cancer after completion of external radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200617047815N1

Enrollment

Registered

2020-08-22

Start date

2017-04-04

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer. Malignant neoplasm of cervix uteri

Interventions

Intervention 1: Intervention group: We performed pelvic MRI for each patient to determine stage of cancer. Then according to three dimensional planing and physics calculation, study participants were

Eligibility

Sex/Gender

Female

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: age less than 70 years old histopathology Adenocarcinoma & squamous cell carcinoma suitable performance status Stage 1b-4a hemoglobin more than 10 Cervical cancer patients Females

Exclusion criteria

Exclusion criteria: Recurrent disease other treatment procedure like surgery

Design outcomes

Primary

Measure	Time frame
The rate of cystitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of proctitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of vaginitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.	—

Measure

Time frame

The rate of cystitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of proctitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.;The rate of vaginitis based on common terminology criteria for adverse events. Timepoint: assess the symptoms before brachytherapy, 0- 30 - 90 days after treatment. Method of measurement: Side effects were recorded by radiation oncologist using the Common terminology criteria for adverse events(CTCAE) guideline.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Garousi

Iran University of Medical Sciences

garousi.m@iums.ac.ir+98 21 2288 4548

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026